Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:34 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 145–168 of 1,666 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Metabolic Complications Clear all

Conditions: 22q11 Deletion Syndrome, DiGeorge Syndrome, Trisomy 21, Trisomy 18, Trisomy 13, Monosomy X, Sex Chromosome Abnormalities, Cri-du-Chat Syndrome, Angelman Syndrome, Prader-Willi Syndrome, 1p36 Deletion Syndrome
Interventions: Not listed
Lead sponsor: Natera, Inc.; Industry
Eligibility: 18 Years to 48 Years · Female only
Enrollment: 20,960 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 16
States / cities: San Francisco, California • Camden, New Jersey • Mount Laurel, New Jersey + 10 more

Conditions: Gestational Diabetes
Interventions: Blood glucose testing; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 293 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 3
States / cities: Danville, Pennsylvania • Providence, Rhode Island • Houston, Texas

Conditions: Congenital Adrenal Hyperplasia
Interventions: Nifedipine; Drug
Lead sponsor: National Center for Research Resources (NCRR); NIH
Eligibility: 14 Years to 35 Years
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Hyperkalemia, Heart Failure
Interventions: patiromer, placebo; Drug
Lead sponsor: Relypsa, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 9
States / cities: Miami, Florida • Port Charlotte, Florida • Peoria, Illinois + 6 more

Conditions: Obesity, Hypertension, Depression
Interventions: 6 week challenge with 1 year of home visits: health texting, in home exercise supports, social support, healthy eating and feeding classes; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: Female only
Enrollment: 175 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Pregnancy, Obesity, Weight Gain, Obstetric Complications
Interventions: Lifestyle intervention; Behavioral
Lead sponsor: St. Louis University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Gestational Diabetes
Interventions: Metformin; Drug
Lead sponsor: Women and Infants Hospital of Rhode Island; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Diabetic Retinopathy
Interventions: Laser Treatment; Procedure
Lead sponsor: National Eye Institute (NEI); NIH
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 2
States / cities: Bethesda, Maryland

Conditions: Osteoporosis, Hypomagnesemia
Interventions: EffCaMgCit, Placebo; Drug · Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 21 Years to 99 Years
Enrollment: 62 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Gestational Diabetes Mellitus
Interventions: Low-Carbohydrate/Higher Fat Diet, High Carbohydrate/Low fat diet; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2015
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: LCAT Deficiency
Interventions: Demographics, diagnosis type, genotype, lipid profile, renal function profile, treatment allocation, ophthalmology exam, country of residence.; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: Not listed
Enrollment: 40 participants
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Preeclampsia, Gestational Diabetes Mellitus (GDM), Preeclampsia (PE), Preeclampsia (PE) Risk, Gestational Diabetes, Gestational Diabetes Mellitus in Pregnancy, Cardiometabolic Diseases, Insulin Resistance, Placental Dysfunction, Pregnancy, Pregnancy Complications, Gestational Complications
Interventions: Not listed
Lead sponsor: University of Tennessee Graduate School of Medicine; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Knoxville, Tennessee

Conditions: Gestational Diabetes
Interventions: Dietary modification and medications; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Polycystic Ovary Syndrome
Interventions: Vitamin D, Placebo; Dietary Supplement · Drug
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Short Bowel Syndrome, Malabsorption, Malnutrition
Interventions: mConnect plus mobile connections to multidisciplinary professionals & peers, iPad use plus one mobile connections to multidisciplinary professionals & peers; Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 13 Years to 30 Years
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Fabry Disease
Interventions: Not listed
Lead sponsor: University of Washington; Other
Eligibility: 1 Day to 90 Years
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 3
States / cities: Decatur, Georgia • Minneapolis, Minnesota • Seattle, Washington

Conditions: X-linked Hypophosphatemia
Interventions: burosumab, Placebo; Biological · Other
Lead sponsor: Kyowa Kirin, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 8
States / cities: Los Angeles, California • San Francisco, California • New Haven, Connecticut + 5 more

Conditions: Glomerular Disease, Bone Diseases, Metabolic, Bone Fracture
Interventions: Dual-energy X-ray absorptiometry, High Resolution Peripheral Quantitative Computed Tomography (HR-pQCT), Blood draw and Urine collection, Questionnaires; Radiation · Other
Lead sponsor: Columbia University; Other
Eligibility: 5 Years to 55 Years
Enrollment: 270 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 2
States / cities: New York, New York • Philadelphia, Pennsylvania

Conditions: Overweight and Obesity, Depression, Postpartum, Mother (Person)
Interventions: Madres para la Salud; Behavioral
Lead sponsor: Arizona State University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 177 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Type 2 Diabetes, Chronic Kidney Disease
Interventions: Dulaglutide, Insulin glargine, Insulin lispro; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 577 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 47
States / cities: Montgomery, Alabama • Azusa, California • Granada Hills, California + 39 more

Conditions: Type 2 Diabetes Mellitus, Chronic Kidney Disease Stage 3
Interventions: Placebo, Sotagliflozin; Drug
Lead sponsor: Lexicon Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 787 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 51
States / cities: Birmingham, Alabama • Guntersville, Alabama • Phoenix, Arizona + 42 more

Conditions: Iron Deficiency Anaemia, Chronic Kidney Disease
Interventions: FCM (Ferric carboxymaltose) high ferritin target, FCM (Ferric carboxymaltose) low ferritin target, Oral Iron (Ferrous sulphate); Drug
Lead sponsor: Vifor Pharma; Industry
Eligibility: 18 Years and older
Enrollment: 626 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Wilmington, North Carolina

Conditions: Gestational Diabetes
Interventions: Exenatide, Buccal/blood Sample Collection; Drug · Genetic
Lead sponsor: Georgetown University; Other
Eligibility: 18 Years to 50 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 2
States / cities: Washington D.C., District of Columbia

Conditions: Type 1 Diabetes, Type 2 Diabetes
Interventions: Not listed
Lead sponsor: VeraLight, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Hyattsville, Maryland

Search by objective public record fields.

SNP-based Microdeletion and Aneuploidy RegisTry (SMART)

Frequency of Blood Glucose Monitoring in Patients With Gestational Diabetes

Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets

Evaluation of Patiromer in Heart Failure Patients

Postpartum Weight Retention

Lifestyle Intervention Forever: Healthy Weight for Pregnancy and Birth (Pilot Study)

A Pragmatic Approach to Lowering the Risk of Diabetes Mellitus After A Diagnosis of Gestational Diabetes Mellitus

Pilot Study of Laser Photocoagulation Therapy for Diabetic Macular Edema

Averting Complications of Proton Pump Inhibitor Therapy by Effervescent Calcium Magnesium Citrate

Role of Macronutrient Diet Composition and Infant Metabolic Outcomes in Gestational Diabetes

LCAT (Lecithin Cholesterol Acyl Transferase) Natural History Study

Cardiometabolic Disease and Substrate Metabolism

Gestational Diabetes Diagnostic Methods

Vitamin D for the Treatment of Women With Polycystic Ovary Syndrome (PCOS)

Teen and Young Adult Connections for Support From Multidisciplinary Professionals & Peers

Podocyturia - Predictor of Renal Dysfunction in Fabry Nephropathy

Study of KRN23 in Adults With X-linked Hypophosphatemia (XLH)

The Impact of Glomerular Disorders on Bone Quality and Strength

Madres Para la Salud (Mothers for Health)

A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)

Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control

Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)

Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes

Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications